Pawel Petryszyn

5PUBLICATIONS
1CO-AUTHORS
Environmental epidemiologyCancer therapy (excl. chemotherapy and radiation therapy)Immunogenetics (incl. genetic immunology)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Dec 25, 2024
The N-Acetyltransferase 2 Polymorphism and Susceptibility to Inflammatory Bowel Disease: A Case-Control Study.

Pawel Petryszyn, Grzegorz Zurakowski, Robert Dudkowiak

|Jun 10, 2022
Aromatase Inhibitors and Risk of Metabolic and Cardiovascular Adverse Effects in Breast Cancer Patients-A Systematic Review and Meta-Analysis.

Kamila Boszkiewicz, Agnieszka Piwowar, Paweł Petryszyn

|Sep 28, 2021
C3435T Polymorphism of the ABCB1 Gene in Polish Patients with Inflammatory Bowel Disease: A Case-Control and Meta-Analysis Study.

Paweł Petryszyn, Robert Dudkowiak, Agnieszka Gruca

|Sep 14, 2020
Infliximab, adalimumab, golimumab, vedolizumab and tofacitinib in moderate to severe ulcerative colitis: comparative cost-effectiveness study in Poland.

Pawel Petryszyn, Pawel Ekk-Cierniakowski, Grzegorz Zurakowski

|Mar 21, 2019
Effectiveness of screening for atrial fibrillation and its determinants. A meta-analysis.

Pawel Petryszyn, Piotr Niewinski, Aleksandra Staniak

Pageof 1

Frequent Collaborators

1 joint publications

Kamila Boszkiewicz